Shares of iRobot (Nasdaq:IRBT) soared to 10.27 percent to $23.28 as of 2 p.m. Thursday, Jan 24, 2013. The increase comes on the heels of the Bedford, Mass. company’s announcement that the remote presence robot developed by iRobot and its telemedicine partner, InTouch Health, has received 510(k) clearance by the by U.S. Food and Drug Administration for use in hospitals.
Six months ago iRobot launched the RP VITA (Remote Presence Virtual + Independent Telemedicine Assistant) at the InTouch Health 7th Annual Clinical Innovations Forum.
iRobot and InTouch Health are hard at work getting the remote-presence automatons into hospitals and health care facilities around the world. So far these initiatives seem to be paying off. InTouch has so far sold its telepresence robots to more than 400 hospitals. Meanwhile, iRobot’s Ava platform recently ranked among Information Week’s “10 Medical Robots That Could Change Healthcare.” The RP VITA robot can interface with diagnostic devices and electronic medical records (EMR) systems. The remote rig will eventually be able to navigate to specified target destinations autonomously.
The Vasteras Giraff is a mobile communication tool that enables the elderly to communicate with the outside world. It’s remote controlled, and it has wheels, a camera and a monitor. The Giraff provides two-way video calling similar to Skype. A caregiver can control the robot using a typical PC. To date, 42 Giraff robots have been delivered to seven European countries, and 20 more were recently built